Credit Suisse’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $11 | Sell |
|
|||||
|
2022
Q3 | $143K | Buy |
|
|||||
|
2022
Q2 | $136K | Sell |
|
|||||
|
2022
Q1 | $409K | Buy |
|
|||||
|
2021
Q4 | $338K | Buy |
|
|||||
|
2021
Q3 | $450K | Buy |
|
|||||
|
2021
Q2 | $458K | Sell |
|
|||||
|
2021
Q1 | $561K | Sell |
|
|||||
|
2020
Q4 | $1.18M | Sell |
|
|||||
|
2020
Q3 | $919K | Buy |
|
|||||
|
2020
Q2 | $296K | Buy |
|
|||||
|
2020
Q1 | $247K | Sell |
|
|||||
|
2019
Q4 | $683K | Buy |
|
|||||
|
2019
Q3 | $574K | Buy |
|
|||||
|
2019
Q2 | $669K | Buy |
|
|||||
|
2019
Q1 | $448K | Sell |
|
|||||
|
2018
Q4 | $501K | Buy |
|
|||||
|
2018
Q3 | $513K | Sell |
|
|||||
|
2018
Q2 | $2.5M | Buy |
|
|||||
|
2018
Q1 | $575K | Sell |
|
|||||
|
2017
Q4 | $817K | Buy |
|
|||||
|
2017
Q3 | $223K | Sell |
|
|||||
|
2017
Q2 | $335K | Sell |
|
|||||
|
2017
Q1 | $816K | Sell |
|
|||||
|
2016
Q4 | $1.55M | Buy |
|
|||||
|
2016
Q3 | $748K | Buy |
|
|||||
|
2016
Q2 | $244K | Buy |
|
|||||
|
2016
Q1 | $76K | Sell |
|
|||||
|
2015
Q4 | $426K | Buy |
|
|||||
|
2015
Q3 | $136K | Buy |
|
|||||
|
2015
Q2 | $177K | Buy |
|
|||||
|
2015
Q1 | $134K | Sell |
|
|||||
|
2014
Q4 | $98K | Sell |
|
|||||
|
2014
Q3 | $237K | Buy |
|
|||||
|
2014
Q2 | $217K | Sell |
|
|||||
|
2014
Q1 | $484K | Sell |
|
|||||
|
2013
Q4 | $631K | Buy |
|
|||||
|
2013
Q3 | $354K | Sell |
|
|||||
|
2013
Q2 | $1.11M | Buy |
|